Investor Alert

Deciphera Pharmaceuticals Inc.



After Hours

 --Quotes are delayed by 20 min

Nov 26, 2021, 2:53 p.m.





+0.08 +0.99%


Volume 2.21m

Quotes are delayed by 20 min


Previous close

$ 8.35

$ 8.07


-0.28 -3.35%

Day low

Day high




52 week low

52 week high




Patricia L. Allen

Patricia L. Allen occupies the position of Chief Financial Officer at Vividion Therapeutics, Inc. She is also on the board of 7 other companies.

In her past career Ms. Allen occupied the position of Treasurer & Vice President for Alnylam Pharmaceuticals, Inc., Finance Director for Alkermes, Inc., CFO, Treasurer & Principal Accounting Officer at Zafgen, Inc. and Auditor for Deloitte & Touche LLP.

Patricia L. Allen received an undergraduate degree from Bryant University.


Date Shares Transaction Value
06/05/2020 5,635   Disposition at $55.9 per share. 314,997
06/05/2020 5,635   Derivative/Non-derivative trans. at $25.73 per share. 144,988
06/03/2020 6,365   Disposition at $59.14 per share. 376,427
06/03/2020 6,365   Derivative/Non-derivative trans. at $25.73 per share. 163,771
01/24/2020 700   Disposition at $67.36 per share. 47,152
01/24/2020 6,496   Disposition at $66.55 per share. 432,309
01/24/2020 17,804   Disposition at $65.93 per share. 1,173,818
01/24/2020 25,000   Derivative/Non-derivative trans. at $3.95 per share. 98,750

Officers and Executives

Mr. Steven L. Hoerter
President, Chief Executive Officer & Director
Mr. Thomas P. Kelly
Chief Financial Officer, Treasurer & Executive VP
Dr. Matthew L. Sherman
Chief Medical Officer & Executive Vice President
Dr. Daniel L. Flynn
Chief Scientific Officer & Executive VP
Dr. Stephen B. Ruddy
Chief Technical Officer
Mr. Eric Haltom
Senior Vice President-Clinical Operations
Mr. Daniel C. Martin
Chief Commercial Officer
Ms. Jennifer Robinson
Head-Investor Relations
Ms. Caroline Chevalier
Vice President-Human Resources
Mr. Jeffrey M. Held
General Counsel & Senior Vice President
Mr. Jama Pitman
Vice President-Regulatory & Quality Assurance
Dr. James A. Bristol
Dr. Susan L. Kelley
Independent Director
Mr. Ron Squarer
Independent Director
Mr. Franklin S. Friedman
Independent Director
Ms. Patricia L. Allen
Independent Director
Dr. Edward J. Benz
Independent Director
Mr. John R. Martin
Independent Director
Mr. Dennis L. Walsh
Independent Director
Trending Tickers
  • /zigman2/quotes/200172674/composite EDSA+102.72%
  • /zigman2/quotes/209901640/composite SPY-1.67%
  • /zigman2/quotes/201343976/composite UVXY+16.31%
  • /zigman2/quotes/221104327/composite LCID+4.83%
  • /zigman2/quotes/214109287/composite SDC-3.13%
Powered by StockTwits
Link to MarketWatch's Slice.